Q-Cells SE files for insolvency proceedings
Q-Cells SE / Key word(s): Insolvency
02.04.2012 14:36
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bitterfeld-Wolfen (Germany), 02 April 2012. Q-Cells SE will file for
insolvency proceedings on Tuesday, 3 April 2012, at the competent
Insolvency Court in Dessau.
Against the background of the final ruling of the Frankfurt Higher Regional
Court in the Pfleiderer case on March 27, 2012, the company had come to the
conclusion that no going concern prognosis is given anymore.
Following an intensive review of alternative concepts for the
implementation of the financial restructuring, the Executive Board has
reached the conclusion that a going concern of the company cannot be
restored on a sufficiently secure legal basis. Therefore the filing for
insolvency proceedings is legally necessary.
The Executive Board and the preliminary insolvency administrator will work
together to secure the continuity of the company within the insolvency
proceedings.
CONTACT
Q-Cells SE
OT Thalheim, Sonnenallee 17-21
06766 Bitterfeld-Wolfen, Germany
FAX +49 (0)3494 6699.10000
WEB www.q-cells.de
Q-Cells Corporate Communications
Ina von Spies, Alberta Rohardt
TEL +49 (0)3494 6699.10121
EMAIL presse@q-cells.com
Q-Cells Investor Relations
Stefan Lissner
TEL +49 (0)3494 6699.10101
EMAIL investor@q-cells.com
Executive Board: Dr Nedim Cen (CEO, CFO), Dr Andreas von Zitzewitz (COO,
CSO)
Chairman of the Supervisory Board: Prof Dr h c Karlheinz Hornung
02.04.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Q-Cells SE
Sonnenallee 17-21, OT Thalheim
06766 Bitterfeld-Wolfen
Germany
Phone: +49 (0)3494 - 6699-0
Fax: +49 (0)3494 - 6699-199
E-mail: q-cells@q-cells.com
Internet: www.q-cells.com
ISIN: DE0005558662, Wandelanleihe 2012: DE000A0LMY64, Wandelanleihe
2014: DE000A1AGZ06, Wandelanleihe 2015: DE000A1E8HF6
WKN: 555866
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Q-Cells SE / Key word(s): Insolvency
02.04.2012 14:36
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Bitterfeld-Wolfen (Germany), 02 April 2012. Q-Cells SE will file for
insolvency proceedings on Tuesday, 3 April 2012, at the competent
Insolvency Court in Dessau.
Against the background of the final ruling of the Frankfurt Higher Regional
Court in the Pfleiderer case on March 27, 2012, the company had come to the
conclusion that no going concern prognosis is given anymore.
Following an intensive review of alternative concepts for the
implementation of the financial restructuring, the Executive Board has
reached the conclusion that a going concern of the company cannot be
restored on a sufficiently secure legal basis. Therefore the filing for
insolvency proceedings is legally necessary.
The Executive Board and the preliminary insolvency administrator will work
together to secure the continuity of the company within the insolvency
proceedings.
CONTACT
Q-Cells SE
OT Thalheim, Sonnenallee 17-21
06766 Bitterfeld-Wolfen, Germany
FAX +49 (0)3494 6699.10000
WEB www.q-cells.de
Q-Cells Corporate Communications
Ina von Spies, Alberta Rohardt
TEL +49 (0)3494 6699.10121
EMAIL presse@q-cells.com
Q-Cells Investor Relations
Stefan Lissner
TEL +49 (0)3494 6699.10101
EMAIL investor@q-cells.com
Executive Board: Dr Nedim Cen (CEO, CFO), Dr Andreas von Zitzewitz (COO,
CSO)
Chairman of the Supervisory Board: Prof Dr h c Karlheinz Hornung
02.04.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Q-Cells SE
Sonnenallee 17-21, OT Thalheim
06766 Bitterfeld-Wolfen
Germany
Phone: +49 (0)3494 - 6699-0
Fax: +49 (0)3494 - 6699-199
E-mail: q-cells@q-cells.com
Internet: www.q-cells.com
ISIN: DE0005558662, Wandelanleihe 2012: DE000A0LMY64, Wandelanleihe
2014: DE000A1AGZ06, Wandelanleihe 2015: DE000A1E8HF6
WKN: 555866
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------